Trial Outcomes & Findings for Effectiveness of Standardized Respiratory Physiotherapy in Primary Care (FREAP) (NCT NCT01152762)

NCT ID: NCT01152762

Last Updated: 2026-08-06

Results Overview

The questionnaire is designed to measure the impact of respiratory symptoms and their treatment on a patient's daily life. It consists of various sections that cover a range of topics related to respiratory health, including symptoms, activity limitations, and overall well-being. The SGRQ questionnaire has 50 items with 76 weighted responses. Scores range from 0 to 100, with higher scores indicating more limitations.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

129 participants

Primary outcome timeframe

Six months

Results posted on

2026-08-06

Participant Flow

Participant milestones

Participant milestones
Measure
Control Group
Normal primary care treatment
Standardized Respiratory Physiotherapy
Standardized Respiratory Physiotherapy is the intervention in all selected patients
Overall Study
STARTED
64
65
Overall Study
COMPLETED
60
62
Overall Study
NOT COMPLETED
4
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effectiveness of Standardized Respiratory Physiotherapy in Primary Care (FREAP)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=64 Participants
Normal primary care treatment
Total
n=129 Participants
Total of all reporting groups
Standardized Respiratory Physiotherapy
n=65 Participants
Standardized Respiratory Physiotherapy is the intervention in all selected patients
Age, Categorical
<=18 years
0 Participants
n=20 Participants
0 Participants
n=40 Participants
0 Participants
n=20 Participants
Age, Categorical
Between 18 and 65 years
26 Participants
n=20 Participants
51 Participants
n=40 Participants
25 Participants
n=20 Participants
Age, Categorical
>=65 years
38 Participants
n=20 Participants
78 Participants
n=40 Participants
40 Participants
n=20 Participants
Age, Continuous
59.8 years
STANDARD_DEVIATION 9.1 • n=20 Participants
60.4 years
STANDARD_DEVIATION 8.3 • n=40 Participants
60.8 years
STANDARD_DEVIATION 7.8 • n=20 Participants
Sex: Female, Male
Female
21 Participants
n=20 Participants
35 Participants
n=40 Participants
14 Participants
n=20 Participants
Sex: Female, Male
Male
43 Participants
n=20 Participants
94 Participants
n=40 Participants
51 Participants
n=20 Participants
Region of Enrollment
Spain
64 participants
n=20 Participants
129 participants
n=40 Participants
65 participants
n=20 Participants

PRIMARY outcome

Timeframe: Six months

Population: 7 participants were excluded from the analysis

The questionnaire is designed to measure the impact of respiratory symptoms and their treatment on a patient's daily life. It consists of various sections that cover a range of topics related to respiratory health, including symptoms, activity limitations, and overall well-being. The SGRQ questionnaire has 50 items with 76 weighted responses. Scores range from 0 to 100, with higher scores indicating more limitations.

Outcome measures

Outcome measures
Measure
Standardized Respiratory Physiotherapy
n=62 Participants
Standardized Respiratory Physiotherapy is the intervention in all selected patients
Control Group
n=60 Participants
Usual clinical practice
St-George Respiratory Questionnaire-SGRQ
29.6 score on a scale
Standard Deviation 20.5
38 score on a scale
Standard Deviation 21.1

PRIMARY outcome

Timeframe: 6 month

The BODE index is a clinical tool used to assess the severity of chronic obstructive pulmonary disease (COPD) and predict the risk of mortality in individuals with this respiratory condition. The BODE Index is a 0 to 10-point scale and it is based on four factors: * Body Mass Index (BMI) * Airflow obstruction (FEV1, as a percentage of the predicted value) * Dyspnea (measured using the MRC dyspnea scale, which ranges from 0 to 4) * Exercise capacity (measured by the 6-minute walk test, in meters) Each factor is assigned a score from 0 to 3 (except for BMI, which can only receive 0 or 1). The total score ranges from 0 to 10, with higher values indicating greater severity and a worse prognosis for COPD.

Outcome measures

Outcome measures
Measure
Standardized Respiratory Physiotherapy
n=62 Participants
Standardized Respiratory Physiotherapy is the intervention in all selected patients
Control Group
n=60 Participants
Usual clinical practice
BODE Index
1.52 score on a scale
Standard Deviation 1.35
1.77 score on a scale
Standard Deviation 1.47

Adverse Events

Standardized Respiratory Physiotherapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Maria Montserrat Inglés Novell

Catalan Health Institute

Phone: +34 977252808

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place